Type
Internal restructuring
Country
France
Region
Location of affected unit(s)
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

158 jobs
Number of planned job losses
Job loss
Announcement Date
13 January 2015
Employment effect (start)
1 September 2015
Foreseen end date

Description

The French subsidiary of US Pharmaeutical group Lilly has announced it will cut about 158 jobs. The group explained that due to a "particularly difficult economic and regulatory environment", Lilly France has "to safeguard its competitiveness". Lilly France has presented to its employee representatives a reorganization plan for the pharmaceutical sales unit which will be implemented from September 2015. This project would lead to the cut "of 158 positions, including 143 posts of medical sales representatives (out of a total of 378 positions), 14 regional director positions and 1 network manager". 


Sources

  • 13 January 2015: Le Monde
  • 13 January 2015: Le Figaro

Citation

Eurofound (2015), Lilly France, Internal restructuring in France, factsheet number 78096, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/78096.